Feedback / Questions
Lynparza (olaparib) - Merck (MSD), AstraZeneca
Imfinzi (durvalumab) - AstraZeneca, BMS
FKB238 (bevacizumab biosimilar) - Fujifilm Kyowa Kirin Biologics, AstraZeneca
http://clinicaltrials.gov/ct2/show/NCT04015739
Mar 25, 2020
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next